Annovis Bio (ANVS) is up 28.3%, or 74c to $3.35.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Promising Alzheimer’s Treatment Advances: Analyst Recommends Buy for Annovis Bio
- Annovis Bio price target lowered to $17 from $26 at Canaccord
- Annovis Bio Appoints New Principal Financial Officer
- Annovis Bio appoints Liu as Director of Biostatistics
- Biotech Alert: Searches spiking for these stocks today